Only half the patients (51%) with moderate to severe OAB had ever been treated with anticholinergic medication. New medications, such as solifenacin,
darifenacin, and botox, were used in only 4.6%, 2.9%, and 2.1% of respondents, respectively.
There has been a major push in neurology to address urinary symptoms in MS patients, but the message is still not getting across, Dr. Mahajan told Medscape Ob/Gyn & Women's Health.